Skip to main content

Published locations for Bruton tyrosine kinase inhibitors improve outcomes in CLL when combined with anti-CD20 mAb

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Bruton tyrosine kinase inhibitors improve outcomes in CLL when combined with anti-CD20 mAb

User login

  • Reset your password
  • /content/bruton-tyrosine-kinase-inhibitors-improve-outcomes-cll-when-combined-anti-cd20-mab
  • /b-cell-lymphoma-icymi/article/264266/b-cell-lymphoma/bruton-tyrosine-kinase-inhibitors-improve